FREE COMMUNICATION 29


14:45 - 16:15     CAPITAL SUITE 14/15/16

Free Communication Session 29 + Mini Lecture

PKD

Chairs: Richard N. Sandford, Cambridge, UK

Mini lecture
Autosomal dominant polycystic kidney disease: new insights into treatment
Imed Helal, Tunis, Tunisia

FREE COMMUNICATIONS

SuO039
LONG TERM EFFECTS OF OCTREOTIDE TREATMENT IN ADPKD PATIENTS WITH POLYCYSTIC LIVER DISEASE (A SUB-GROUP ANALYSIS OF THE ALADIN TRIAL)
Antonio Pisani1, Piero Ruggenenti2, Giuseppe Remuzzi2, Eleonora Riccio3, Massimo Sabbatini1, 1Federico II, Nephrology, Naples, ITALY, 2Mario Negri, Nephrology, Bergamo, ITALY, 3Federico II Univ, Nephrology, Naples, ITALY.

SuO040
EFFECT OF DOSE TITRATION OF A VASOPRESSIN V2 RECEPTOR ANTAGONIST TO IMPROVE RENOPROTECTION IN EXPERIMENTAL POLYCYSTIC KIDNEY DISEASE
Debbie Zittema1, Irina Versteeg1, Esther Meijer1, Harry van Goor2, Dorien JM Peters3, Ron T Gansevoort1, 1UMC Groningen, Nephrology, Groningen, NETHERLANDS, 2UMC Groningen, Pathology, Groningen, NETHERLANDS, 3Leiden UMC, Human Genetics, Leiden, NETHERLANDS.

SuO041
BONE MARROW MESENCHYMAL STROMAL CELLS REDUCED CYSTOGENIC POTENTIAL OF CD133+ PROGENITOR CELLS OF HUMAN POLYCYSTIC KIDNEYS
Sara Hajibabaei1, Reza Moghadasali1, Mahmood Dehghani Ashkezari2, Farid Dadkhah3, Nasser Simfroosh4, Mohammad Reza Ghadirzadeh5, Ali Reza Kadkhodaei5, Ali Ziaie5, Nasser Aghdami1, 1Royan Inst Stem Cell Biology and Technology, ACECR, Dept Stem Cells and Developmental Biology at Cell Sciences Research Center, Tehran, IRAN, 2Islamic Azad Univ, Ashkezar Branch, Dept Biology, Yazd, IRAN, 3Shaheed Modarres Hosp, Shaheed Beheshti Univ Medical Sciences, Dept Urology, Tehran, IRAN, 4Shahid Labbafinejad Hosp, Shahid Beheshty Univ Medical Sciences, Urology and Nephrology Research Center, Tehran, IRAN, 5Iranian Legal Medicine Organization, Legal Medicine Research Center, Tehran, IRAN.

SuO042
POLYCYSTIN-1 TRAFFICKING IS REGULATED BY CAMP DEPENDENT PHOSPHORYLATION OF THE PLAT DOMAIN.
Andrew J. Streets, Yaoxian Xu, Albert C.M. Ong, Univ Sheffield, Academic Unit Nephrology, Sheffield, UK

SuO043
IS COPEPTIN A SPECIFIC MARKER OF CKD IN ADPKD PATIENTS?
Valentina Corradi1, Francesca Martino1, Fiorella Gastaldon1, Elisa Scalzotto1, Carlotta Caprara1, Antonio Fortunato2, Giulia Pinaffo2, Cristina Marchetti2, Francesca Fabbi2, Davide Giavarina2, Claudio Ronco1, 1Osp San Bortolo, Nephrology, Dialysis and Transplant &IRRIV, Vicenza, ITALY, 2Osp San Bortolo, Clinical Chemistry and Haematology Lab, Vicenza, ITALY.

back to the timetable